Blackbaud holder plans sale of 22,000 shares

A holder of Blackbaud, Inc. common stock filed a notice of proposed sale for up to 22,000 shares through Merrill Lynch, One Bryant Park, New York, with an aggregate market value of $993,520.

Rhea-AI Filing Summary

A holder of Blackbaud, Inc. common stock filed a notice of proposed sale for up to 22,000 shares through Merrill Lynch, One Bryant Park, New York, with an aggregate market value of $993,520. Shares outstanding were 45,390,097, with the contemplated sale date of 08/06/2026 on NASDAQ.

The filing also lists compensatory equity awards in the form of restricted stock units scheduled to vest on various dates in 2025 and 2026, covering share amounts of 604, 5,461, 6,986, 1,977, 5,353, and 1,619, each described as a compensatory payment by the issuer.

Key Figures

Proposed shares to be sold: 22,000 shares Aggregate market value of proposed sale: $993,520 Shares outstanding: 45,390,097 shares +5 more

8 metrics

Proposed shares to be sold 22,000 shares Common stock sale contemplated via Merrill Lynch

Aggregate market value of proposed sale $993,520 Total value for 22,000 shares of common stock

Shares outstanding 45,390,097 shares Outstanding Blackbaud common stock at time referenced

Contemplated sale date 08/06/2026 Proposed date for sale of 22,000 shares on NASDAQ

RSU vest 1 604 shares Restricted Stock Unit vesting on 02/18/2025 as compensatory payment

RSU vest 2 5,461 shares Restricted Stock Unit vesting on 02/19/2025 as compensatory payment

RSU vest 3 6,986 shares Restricted Stock Unit vesting on 02/21/2025 as compensatory payment

RSU vest 4 1,977 shares Restricted Stock Unit vesting on 08/06/2025 as compensatory payment

Key Terms

Form 144, Restricted Stock Unit Vest, Compensatory Payment

3 terms

Form 144 regulatory

"Form 144 for BLKB reports a proposed sale of up to 22,000 shares"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Unit Vest financial

"RSU vests are labeled as Restricted Stock Unit Vest with specific share amounts"

Compensatory Payment financial

"Each RSU vest is described as a Compensatory Payment by the issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is being proposed in the Form 144 for BLKB?

The Form 144 for BLKB reports a proposed sale of up to 22,000 shares of Blackbaud common stock. The filing lists an aggregate market value of $993,520 for these shares and identifies trading on the NASDAQ with a proposed sale date of 08/06/2026.

What is the aggregate market value of the Blackbaud (BLKB) shares in this proposed sale?

The aggregate market value of the proposed Blackbaud BLKB share sale is reported as $993,520. This value relates to the planned disposition of 22,000 shares of common stock, as indicated in the Form 144 notice filed through Merrill Lynch for trading on NASDAQ.

How many Blackbaud (BLKB) shares are outstanding according to this filing?

The filing states that 45,390,097 shares of Blackbaud BLKB common stock were outstanding. This figure provides context for the proposed sale of 22,000 shares, helping investors gauge the relative size of the planned transaction compared with total outstanding shares.

When is the proposed sale date for the Blackbaud (BLKB) shares in this Form 144?

The proposed sale date for the Blackbaud BLKB common shares is listed as 08/06/2026. The notice contemplates selling up to 22,000 shares through Merrill Lynch on NASDAQ, with an aggregate reported market value of $993,520 tied to this proposed transaction.

What restricted stock unit (RSU) vesting events are disclosed for BLKB?

The filing lists RSU vests for Blackbaud BLKB on several dates in 2025 and 2026, with share amounts of 604, 5,461, 6,986, 1,977, 5,353, and 1,619. Each entry is identified as a Restricted Stock Unit Vest and described as a Compensatory Payment by the issuer.

Through which broker and market will the BLKB shares in this notice be sold?

The proposed sale of Blackbaud BLKB shares is listed through Merrill Lynch, One Bryant Park, New York as broker. The common stock is indicated for trading on the NASDAQ market, with a contemplated sale of up to 22,000 shares at an aggregate value of $993,520.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/06/2026 - 04:40 PM Accepted by SEC EDGAR 08/06/2026 - 04:40 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001601818
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Blackbaud Inc
SEC File Number	001-41527
Address of Issuer	65 Fairchild Street Charleston SOUTH CAROLINA 29492
Phone	843-216-6200
Name of Person for Whose Account the Securities are To Be Sold	Kevin Gregoire
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch One Bryant Park New York NY 10036	22000	993520	45390097	08/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/18/2025	Restricted Stock Unit Vest	Issuer			604	02/18/2025	Compensatory Payment
Common Stock	02/19/2025	Restricted Stock Unit Vest	Issuer			5461	02/19/2025	Compensatory Payment
Common Stock	02/21/2025	Restricted Stock Unit Vest	Issuer			6986	02/21/2025	Compensatory Payment
Common Stock	02/22/2025	Restricted Stock Unit Vest	Issuer			1977	08/06/2025	Compensatory Payment
Common Stock	02/24/2025	Restricted Stock Unit Vest	Issuer			5353	02/24/2025	Compensatory Payment
Common Stock	02/13/2026	Restricted Stock Unit Vest	Issuer			1619	02/13/2026	Compensatory Payment

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/06/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Kevin Gregoire
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)